Medication info
Innoen Abel Tablet 300 Milligrams (Irbesartan)

Innoen Abel Tablet 300 Milligrams (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›300mg / 1 tablet
Manufacturer / importer
HK InnoEN Co., Ltd.
Appearance
White or almost white, oval film-coated tablet with both sides convex
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201101761 · Notified 2011.03.29 · Insurance code 640006020

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
HK InnoEN Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication helps effectively lower blood pressure in patients with essential hypertension. It is also used to manage kidney disease in patients with hypertension and type 2 diabetes. By controlling blood pressure and protecting kidney health, it contributes to improving the overall treatment efficacy for patients. Therefore, it is widely used in the treatment of essential hypertension and diabetic kidney disease accompanying hypertension.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who may become pregnant or are breastfeeding should not take this medication. It should not be administered to patients with hypersensitivity to this medication or certain genetic disorders, or severe liver impairment. Caution should be exercised for specific patient groups such as the elderly, patients with compromised liver function, and patients with reduced kidney function, and blood pressure, kidney function, and electrolyte status should be monitored periodically. Since blood pressure may drop sharply, special caution is necessary when first starting this medication or when taken together with other antihypertensive agents. This medication may cause hyperkalemia, so patients with high potassium levels or those taking potassium supplements should exercise caution. There may be drug interactions, so especially if taking diuretics, potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs, consult a physician. Dizziness or fatigue may occur while taking this medication, so caution is needed when driving or operating machinery. In case of overdose, symptoms such as hypotension and tachycardia may occur, so consult healthcare professionals immediately if any abnormal symptoms arise. Keep out of reach of children and do not transfer to other containers for safety.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal trauma
  • chest pain
Show 122 more
  • dyspepsia/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial swelling
  • arm swelling
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormality
  • cardiac respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • chest pain
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disturbances
  • paralysis
  • somnolence
  • emotional disorders
  • depression
  • sensory abnormalities
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • ear discharge
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic hypotension
  • orthostatic shock
  • plasma creatine kinase increase
  • hyperkalemia
  • hypersensitivity reaction
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • plasma creatine kinase increase
  • arthralgia
  • tachycardia
  • hepatitis
  • liver dysfunction
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis
  • palpitations
  • constipation
  • dyspnea
  • hypesthesia
  • hypertriglyceridemia
  • insomnia
  • dysgeusia
  • polydipsia
  • abdominal distention
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • surface
  • itching
  • granulocytopenia
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it is recommended to store it in a cool and dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, oval film-coated tablet with both sides convex

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.